Product Image

Alaska Wild Fish Oil Mega Omega-3

21st Century
4.8
★ ★ ★ ★ ★
(884 ratings)
EPA (Eicosapentaenoic Acid) 965 mg
Fish Oil 1950 mg
DHA 385 mg
Product Image
Score84
A potent, affordable EPA-led fish oil with excellent active dosing, held back mainly by missing quality-verification details.
How scoring works
Quantity:90 Softgel(s) • (30 servings)
Goals:
Cardiovascular Support
Heart Health
Anti-Inflammatory Support
Mental Focus

Score 84

A potent, affordable EPA-led fish oil with excellent active dosing, held back mainly by missing quality-verification details.
How scoring works
$12.58($0.41 per serving)
iHerb
$ 16.99
Pure Formulas
$ 12.58
Report prices

Analysis

Three softgels provide 965 mg EPA and 385 mg DHA from 1,950 mg of fish oil. The high active concentration and EPA-forward ratio suit targeted cardiovascular and inflammatory support.

Wild Alaskan sourcing adds useful origin context. Fish species, molecular form, oxidation protection, and contaminant testing are not supplied, so oil quality cannot be judged fully.

Active-dose value is strong for such a concentrated formula. The three-softgel serving is the main convenience trade-off, and the product is more relevant to long-term nutritional support than immediate mental focus.

Who is it for
  • Adults seeking high EPA intake
  • People targeting cardiovascular or inflammatory support
  • Value-conscious users comfortable with three softgels
Best for
  • EPA-focused omega-three support
  • Cardiovascular routines
  • Inflammatory-balance support

Pros

  • High EPA amount
  • Clearly separated EPA and DHA
  • Strong active-dose value

Cons

  • Three-softgel serving
  • Molecular form and fish species are unstated
  • No antioxidant or purity-testing details

Warnings

  • Fish oil may increase bleeding tendency with anticoagulants
  • Avoid with a fish allergy
  • High-dose omega-threes may cause reflux or loose stools

Nutrient quality

87 Highest impact

High EPA and DHA amounts strongly support the intended omega-3 use with little apparent padding. The unidentified molecular form prevents a stronger quality assessment.

.

Ingredient transparency

81 Highest impact

EPA and DHA are separately quantified with no proprietary blend. Oil form, species, inactive ingredients, and purity controls are not shown in the supplied label data.

.

Customer satisfaction

71 High impact

The aggregate rating is strong and supported by a large review count. No review text is supplied to establish repeated complaints or specific experience with the intended purpose.

.

Value for money

95 Highest impact

A large active omega-3 amount and high concentration support excellent serving value. Missing testing and form disclosures are the main quality limitations relative to premium competitors.

.
Report analysis

Goals

Cardiovascular Support
Impact
Highest effect
A+ Goal FitA+ Strength of SupportB- CoverageA+ Formula Quality
Fish Oil · 1950 mg

A high disclosed EPA and DHA amount provides strong support for triglyceride management and cardiovascular cell membranes. The focused oil does not directly cover nitric oxide, magnesium-dependent rhythm, or homocysteine pathways.

The EPA and DHA quantities are fully stated and reach a substantial daily amount. Enteric-coated softgels provide practical delivery without hidden blends or decorative actives.

Study evidence
Fish Oil Supportive 185 studies
Heart Health
Impact
Highest effect
A+ Goal FitA- Strength of SupportB- CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 965 mg

The formula provides a high, clearly separated EPA and DHA amount strongly aligned with lipid and inflammatory support. Human cardiovascular evidence for EPA and DHA is extensive, particularly for triglyceride management.

EPA is the dominant fatty acid and total EPA plus DHA reaches a meaningful daily level. The molecular form, oxidation protection, and contaminant-testing details are not disclosed.

Study evidence
Anti-Inflammatory Support
Impact
Highest effect
A+ Goal FitA Strength of SupportC+ CoverageA+ Formula Quality
Fish Oil · 1950 mg

A concentrated amount of EPA and DHA provides strong support for resolving inflammatory signaling. The individually listed fatty acids make the active dose easy to judge.

The formula is focused and reaches a useful combined omega-3 amount. Confidence is limited by missing molecular-form, purification, independent-testing, and antioxidant-stability details.

Mental Focus
Impact
High effect
D+ Goal FitB- Strength of SupportD+ CoverageA Formula Quality

EPA and DHA support long-term brain structure and inflammatory balance, but they are not acute focus enhancers. The high EPA-centered serving may be more relevant to cognitive resilience than immediate concentration.

The fatty-acid amounts are transparent and substantial. Missing molecular-form, antioxidant, and contaminant-testing details limit confidence in delivery and quality.

Study evidence

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Total Fat
2 Gram(s)
Polyunsaturated Fat
1.5 Gram(s)
Cholesterol
10 mg
Fish Oil
1950 mg
Total EPA/DHA Omega-3
1350 mg
Eicosapentaenoic Acid
965 mg
Docosahexaenoic Acid
385 mg
Gluten Free Adults 18–50
Report overview
C- Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value

The molecular form is unspecified, but EPA is highly concentrated within the listed EPA-and-DHA total. The dose is high and strongly EPA-centered, making the composition well aligned with this collection. Excellent cost efficiency is tempered by missing antioxidant and contaminant-testing disclosures.

Fish Oil · 1950 mg OverallScore56
F Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyA+ Value

The oil delivers an effective, highly concentrated amount of individually disclosed EPA and DHA at excellent cost efficiency. Wild Alaskan sourcing adds useful origin information, though the species and sustainability certification are not stated. Its molecular form, purification process, independent testing, and antioxidant protection remain unclear.

DHA · 385 mg OverallScore37
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyC Value
The DHA amount is moderate and EPA plus DHA make up a strong share of the fish oil. Alaska sourcing adds some origin detail, but no species, chemical form, antioxidant system, or independent purity testing is disclosed. Cost per gram is moderate, while the three-softgel serving may be less convenient.
Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.
    Manson JE; Bassuk SS; Cook NR; Lee IM; Mora S; Albert CM; Buring JE; VITAL Research Group · Circulation research · 2020
    Randomized trial25,871 participantsCardiovascular Support forFish Oil
  2. Effect of fish oil supplement in maintenance hemodialysis patients: a systematic review and meta-analysis of published randomized controlled trials.
    He L; Li MS; Lin M; Zhao TY; Gao P · European journal of clinical pharmacology · 2016
    Meta-analysis916 participants13 studies pooledAnti-Inflammatory Support forFish Oil
  3. Marine n-3 fatty acid treatment for carotid plaques in patients with type 2 diabetes.
    Zhuang P; Liu X; Jia W; Zheng W; Wan X; Chen W; Gu J; Li Y; Lan X; Li H; Tong W; Wu Y; Wu X; Ao Y; Ye H; Wu F; Zhu L; Zhang L; Li Y; Meng D; Tian Y; Wang A; Wu S; Zhu F; Zhang Y; Shi H; Yu X; Zhang F; Zhang Y; Jiao J · Cardiovascular diabetology · 2026
    Randomized trial415 participantsCardiovascular Support forFish Oil
  4. No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals.
    Pot GK; Brouwer IA; Enneman A; Rijkers GT; Kampman E; Geelen A · European journal of clinical nutrition · 2010
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  5. Fish oil, enriched with polyunsaturated fatty acids of the omega-3-type accelerates the nucleation time in healthy subjects.
    Janowitz P; Swobodnik W; Wechsler JG; Janowitz A; Saal D; Ditschuneit H · Klinische Wochenschrift · 1991
    Non-randomized trial24 participantsCardiovascular Support forFish Oil
  6. Effects of fish oil supplementation on biomarkers of vascular endothelial function in middle-aged and older adults: a randomized controlled trial.
    Quan C; Tang W; Qin Y; Nian Z; Li Z; Mao L · Food & function · 2026
    Randomized trial240 participantsAnti-Inflammatory Support forFish Oil
  7. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  8. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  9. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  10. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  11. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  12. Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials.
    Chen X; Hong S; Sun X; Xu W; Li H; Ma T; Zheng Q; Zhao H; Zhou Y; Qiang Y; Li B; Li X · Nutrition reviews · 2021
    Meta-analysis927 participants18 studies pooledAnti-Inflammatory Support forFish Oil
  13. Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study.
    Li ZH; Zhong WF; Liu S; Kraus VB; Zhang YJ; Gao X; Lv YB; Shen D; Zhang XR; Zhang PD; Huang QM; Chen Q; Wu XB; Shi XM; Wang D; Mao C · BMJ (Clinical research ed.) · 2020
    Cohort study427,678 participantsCardiovascular Support forFish Oil
  14. The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients.
    Deike E; Bowden RG; Moreillon JJ; Griggs JO; Wilson RL; Cooke M; Shelmadine BD; Beaujean AA · Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2013
    Randomized trial31 participantsAnti-Inflammatory Support forFish Oil
  15. Regular use of fish oil supplements and course of cardiovascular diseases: prospective cohort study.
    Chen G; Qian ZM; Zhang J; Zhang S; Zhang Z; Vaughn MG; Aaron HE; Wang C; Lip GY; Lin H · BMJ medicine · 2024
    Cohort study415,737 participantsCardiovascular Support forFish Oil
  16. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  17. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  18. A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer.
    Mocellin MC; Camargo CQ; Nunes EA; Fiates GMR; Trindade EBSM · Clinical nutrition (Edinburgh, Scotland) · 2017
    Meta-analysis475 participants9 studies pooledAnti-Inflammatory Support forFish Oil
  19. Cardiovascular Benefits of Fish-Oil Supplementation Against Fine Particulate Air Pollution in China.
    Lin Z; Chen R; Jiang Y; Xia Y; Niu Y; Wang C; Liu C; Chen C; Ge Y; Wang W; Yin G; Cai J; Clement V; Xu X; Chen B; Chen H; Kan H · Journal of the American College of Cardiology · 2020
    Randomized trial65 participantsCardiovascular Support forFish Oil
  20. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  21. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  22. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  23. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  24. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  25. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  26. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  27. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  28. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  29. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  30. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)